Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia (Syphilaxis)
Sponsor: Kirby Institute
A observational or N/A phase clinical study on STIs Prevention, this trial is ongoing. The trial is conducted by Kirby Institute and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Dec 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2025 — Dec 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 8 earlier versions
-
May 2022 — Nov 2023 [monthly]
Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2019 — Mar 2020 [monthly]
Not Yet Recruiting
-
Nov 2018 — Dec 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Kirby Institute
- Monash University
- South Australian Health and Medical Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .